Prezista generic
Prezista is an antiviral drug owned by Janssen Prods. The active ingredient in Prezista is darunavir. This drug first received market authorization on 23 June, 2006 and is available in tablet form for oral administration.
When will Prezista generic be available?
The generics of Prezista are expected to become available after 26 June, 2027. This generic release date is based on the expiration of the last pertinent patent - US7700645*PED, titled 'Pseudopolymorphic forms of a HIV protease inhibitor'.
Prezista uses
Prezista, containing the active ingredient darunavir, is primarily used in the treatment of HIV infection. darunavir interferes with an enzyme known as HIV protease, disrupting the virus's ability to replicate and spread in the body.
Prezista patent expiration
Prezista is protected by 4 patents, none of which have expired. The last patent, US7700645*PED, is due to expire on June 26, 2027. Below are the details of the patent: